Skip to main content
SpringerLink
Log in

High frequency of splice site mutation in 21-hydroxylase deficiency children

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Purpose

Steroid 21-hydroxylase deficiency (21-OHD) is the common type of congenital adrenal hyperplasia (CAH) caused by defects in the CYP21A2 gene, as an autosomal recessive disease, genetic analysis has a prominent role in its diagnosis. Our objectives were to determine the prevalence of common mutations in a group of Egyptian patients with 21-OHD and their families using rapid methods, and also to detect the rate of deletion, duplication and conversions in CYP21A2 gene.

Methods

Rapid detection methods were used: allele-specific PCR for c.293-13A>G (g.659A>G), c.518T>A (p.I172N) variants and c.332_339del (8-bp deletion in exon 3), and real-time, quantitative PCR assay was used to detect deletion in the CYP21A2 gene. 29 Egyptian patients, 38 family members, and 20 healthy controls were all included in the study.

Results

The frequency of c.293-13A>G splice mutation was reported in 96.6 % cases, G allele had 2.5-folds higher risk to develop CAH than other alleles. The c.518T>A mutation was reported in 69 % cases, children carrying the mutant allele were 2.1 times more risk. The most frequent combined mutations detected were c.293-13A/C>G/c.518T>A in 58.6 % cases.

Conclusion

The genetic analysis of the splice site mutation c.293-13A>G and c.518T>A variant can be used as good biomarkers for early detection of cases and carriers in 21-OHD CAH Egyptian children, since the methods used have rapid turnaround time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Morel Y, Miller WL (1991) Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Adv Hum Genet 20:1–68

    Article  CAS  PubMed  Google Scholar 

  2. White PC, Tusie-Luna MT, New MI, Speiser PW (1994) Mutations in steroid 21-hydroxylase (CYP21). Hum Mut 3:373–378

    Article  CAS  PubMed  Google Scholar 

  3. New MI (1995) Steroid 21-hydroxylase deficiency (congenital adrenal hyperplasia). Am J Med 98(1A):S2–S8

    Article  Google Scholar 

  4. Speiser PW (2004) Congenital adrenal hyperplasia. In: Pescovitz OH, Eugster EA (eds) Pediatric endocrinology: mechanism, manifestations and management. Lippincott Williams and Wilkins, Philadelphia, pp 600–613

    Google Scholar 

  5. Merke DP, Bornstein SR (2005) Congenital adrenal hyperplasia. Lancet 365:2125–2136

    Article  PubMed  Google Scholar 

  6. White PC, Speiser PW (2000) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21:245–291

    CAS  PubMed  Google Scholar 

  7. Speiser PW (2001) Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Endocrinol Metab Clin North Am 30:31–59

    Article  CAS  PubMed  Google Scholar 

  8. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI (1985) High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 37:650–667

    PubMed Central  CAS  PubMed  Google Scholar 

  9. White PC, Grossberger D, Onufer BJ, Chaplin DD, New MI, Dupont B, Strominger JL (1985) Two genes encoding steroid 21-hydroxylase are located near the genes encoding he fourth component of complement in man. Proc Natl Acad Sci USA 82:1089–1093

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Higashi Y, Yoshioka H, Yamane M, Gotoh O, Fujii-Kuriyama Y (1986) Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci USA 83:2841–2845

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Nimkarn SI, New MI (2007) Prenatal diagnosis and treatment of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Nat Clin Pract Endocrinol Metab 3:405–413

    Article  CAS  PubMed  Google Scholar 

  12. White PC, New MI, Dupont B (1986) Structure of human steroid 21-hydroxylase genes. Proc Natl Acad Sci USA 83:5111–5115

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Forest MG (2004) Recent advances in diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod Update 10:469–485

    Article  CAS  PubMed  Google Scholar 

  14. Haider S, Islam B, D’Atri V, Sgobba M, Poojari C, Sun L, Yuen T, Zaidi M, New MI (2013) Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia. Proc Natl Acad Sci USA 12(110):2605–2610

    Article  Google Scholar 

  15. Helmberg A, Tusie-Luna MT, Tabarelli M, Kofler R, White PC (1992) R339H and P453S: CYP21 mutations associated with nonclassic steroid 21-hydroxylase deficiency that are not apparent gene conversions. Mol Endocrinol 6:1318–1322

    CAS  PubMed  Google Scholar 

  16. Temtamy S, Aglan M (2012) Consanguinity and genetic disorders in Egypt. Middle East J Med Genet 1:12–17

    Article  Google Scholar 

  17. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC (2010) Endocrine society: congenital adrenal hyperplasia due to steroid 21 hydroxylase deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 95:4133–4160

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, Smith JC, Markham AF (1989) Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 17:2503–2516

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Krone N, Braun A, Weinert S, Peter M, Roscher A, Partsch C (2002) Multiplex minisequencing of the 21-hydroxylase gene as a rapid strategy to confirm congenital adrenal hyperplasia. Clin Chem 48:818–825

    CAS  PubMed  Google Scholar 

  20. Weisenpacherová R, Pribilincová Z, Behulová R, Mezenská R, Lukáčová M (2004) Mutational analysis of CYP21 gene in Slovak patients with 21-hydroxylase deficiency and comparison with other European populations. Biol Bratisl 59:795–802

    Google Scholar 

  21. Olney R, Mougey E, Wang J, Shulman D, Sylvester J (2002) Using real-time, quantitative PCR for rapid genotyping of the steroid 21-hydroxylase gene in a north Florida population. J Clin Endocrinol Metab 87:735–741

    Article  CAS  PubMed  Google Scholar 

  22. Lee C, Tung Y, Hsiao P, Lee J, Tsai W (2010) Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in the pre-screening era. J Formos Med Assoc 109:148–155

    Article  CAS  PubMed  Google Scholar 

  23. Speiser PW, White PC (2003) Congenital adrenal hyperplasia. N Engl J Med 21(349):776–788

    Article  Google Scholar 

  24. Wedell A (1998) Molecular genetics of congenital adrenal hyperplasia (21-hydroxylase deficiency): implications for diagnosis, prognosis and treatment. Acta Paediatr 87:159–164

    Article  CAS  PubMed  Google Scholar 

  25. New MI, Abraham M, Gonzalez B, Dumic M, Razzaghy-Azar M, Chitayat D, Sun L, Zaidi M, Wilson RC, Yuen T (2013) Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci USA 12(110):2611–2616

    Article  Google Scholar 

  26. Menabò S, Balsamo A, Baldazzi L, Barbaro M, Nicoletti A, Conti V, Pirazzoli P, Wedell A, Cicognani A (2012) A sequence variation in 3′UTR of CYP21A2 gene correlates with a mild form of congenital adrenal hyperplasia. J Endocrinol Invest 35:298–305

    PubMed  Google Scholar 

  27. Khan AH, Aban M, Raza J, Ul Haq N, Jabbar A, Moatter T (2011) Ethnic disparity in 21-hydroxylase gene mutations identified in Pakistani congenital adrenal hyperplasia patients. BMC Endocr Disord 11:5

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Balraj P, Lim PG, Sidek H, Wu LL, Khoo AS (2013) Mutational characterization of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Malaysia. J Endocrinol Invest. 36:366–374

    CAS  PubMed  Google Scholar 

  29. Torres N, Mello M, Germano C, Elias L, Moreira M, Castro M (2003) Phenotype and genotype correlation of the microconversion from the CYP21A1P to the CYP21A2 gene in congenital adrenal hyperplasia. Braz J Med Biol Res 36:1311–1318

    Article  CAS  PubMed  Google Scholar 

  30. Bobba A, Marra E, Giannattasio S, Iolascon A, Monno F (1999) 21-hydroxylase deficiency in Italy: a distinct distribution pattern of CYP21 mutations in a sample from southern Italy. J Med Genet 36:648–650

    PubMed Central  CAS  PubMed  Google Scholar 

  31. White P, Speiser P (2000) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21:245–291

    CAS  PubMed  Google Scholar 

  32. Dolzan V, Sólyom J, Fekete G, Kovács J, Rakosnikova V, Votava F, Lebl J, Pribilincova Z, Baumgartner-Parzer SM, Riedl S, Waldhauser F, Frisch H, Stopar-Obreza M, Krzisnik C, Battelino T (2005) Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia. Eur J Endocrinol 153:99–106

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

All authors declare that there is no commercial affiliation or consultancy of any of the authors that could be construed as a conflict of interest with respect to the submitted data.

Author information

Authors and Affiliations

  1. Department of Clinical and Chemical Pathology, Cairo University, Cairo, 11562, Egypt

    S. Sharaf, D. ElAbd, A. Ismail, G. Thabet & M. Elsharkawy

  2. Department of Pediatrics, Kasr Al-Aini Hospital, Cairo University, Cairo, Egypt

    M. Hafez

  3. Faculty of Medicine, Kasr Al-Aini Hospital, Cairo University, Cairo, 11562, Egypt

    M. Elsharkawy

Authors
  1. S. Sharaf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Hafez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. ElAbd
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Ismail
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Thabet
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Elsharkawy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Elsharkawy.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sharaf, S., Hafez, M., ElAbd, D. et al. High frequency of splice site mutation in 21-hydroxylase deficiency children. J Endocrinol Invest 38, 505–511 (2015). https://doi.org/10.1007/s40618-014-0207-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-014-0207-1

Keywords

Search

Navigation